Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Petros Pharmaceuticals develops innovative healthcare technology platforms to facilitate Rx-to-OTC drug switches. Its primary focus is on creating SaaS and SaMD solutions that help pharmaceutical companies navigate regulatory approval, enhance consumer self-selection, and expand access to nonprescription medications. The company licenses its proprietary technology, targeting the self-care market and emerging health tech collaborations, while shifting away from direct product sales.
This description was generated via AI from an annual report. Updated about 1 year ago.